Increased Bilirubin - Search News

Intellia Pauses Patient Dosing, Screening in Trials

Intellia pauses phase 3 CRISPR trials after patient is hospitalized

Intellia paused both trials after receiving a report of grade 4 liver enzymes and increased total bilirubin in a patient in the ATTR-CM trial. The patient was hospitalized, is being closely monitored and is undergoing treatment, according to the biotech.

· 15h · on MSN

Intellia pauses gene therapy trials after patient suffers liver injury, shares slide

· 15h

Intellia stock tumbles after pausing gene therapy trials on safety concerns

4 ways to naturally lower bilirubin levels and improve your overall liver health

To improve liver health and decrease bilirubin levels, you should make sure to stay hydrated, avoid alcohol, and eat high ...

Stocktwits on MSN

Why Did NTLA Stock Tumble 43% Pre-Market Today?

Intellia said that it has temporarily paused patient dosing and screening for two of its late-stage trials for Nex-z. ・The ...

12h

Intellia Shares Sink After Drug Trial Halted on Safety Concerns

Shares of Intellia sank after the company paused patient dosing and screening for trials of its nex-z drug after on participant in the study reported signs of liver injury. The stock fell 46% to ...

WMRA

Newborn babies benefit from painless jaundice monitors at local clinic

A Rockingham-area health center has used local grant funding to purchase equipment to monitor and treat jaundice in newborn ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results